MA52979A - Procédé de préparation d'un composé thiazole puissant, formulation pharmaceutique et utilisations associées - Google Patents
Procédé de préparation d'un composé thiazole puissant, formulation pharmaceutique et utilisations associéesInfo
- Publication number
- MA52979A MA52979A MA052979A MA52979A MA52979A MA 52979 A MA52979 A MA 52979A MA 052979 A MA052979 A MA 052979A MA 52979 A MA52979 A MA 52979A MA 52979 A MA52979 A MA 52979A
- Authority
- MA
- Morocco
- Prior art keywords
- powerful
- preparation
- pharmaceutical formulation
- thiazole compound
- related uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201821015990 | 2018-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52979A true MA52979A (fr) | 2021-04-28 |
Family
ID=68294614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052979A MA52979A (fr) | 2018-04-27 | 2019-04-26 | Procédé de préparation d'un composé thiazole puissant, formulation pharmaceutique et utilisations associées |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12440478B2 (fr) |
| EP (1) | EP3799593A4 (fr) |
| JP (1) | JP7520810B2 (fr) |
| AU (1) | AU2019260644B2 (fr) |
| BR (1) | BR112020022016A2 (fr) |
| CA (1) | CA3098522A1 (fr) |
| IL (1) | IL278322B2 (fr) |
| MA (1) | MA52979A (fr) |
| SG (1) | SG11202010623YA (fr) |
| WO (1) | WO2019207548A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130759C (fr) * | 1965-10-07 | |||
| JP2009531289A (ja) | 2006-02-10 | 2009-09-03 | ライフ テクノロジーズ コーポレーション | オリゴ糖によるタンパク質の修飾及び標識方法 |
| ES2690315T3 (es) | 2012-06-15 | 2018-11-20 | Mitsubishi Tanabe Pharma Corporation | Compuestos de imidazol y triazol como inhibidores de DGAT-1 |
| WO2015172196A1 (fr) * | 2014-05-13 | 2015-11-19 | Monash University | Composés hétérocycliques et leur utilisation |
-
2019
- 2019-04-26 MA MA052979A patent/MA52979A/fr unknown
- 2019-04-26 CA CA3098522A patent/CA3098522A1/fr active Pending
- 2019-04-26 JP JP2021508343A patent/JP7520810B2/ja active Active
- 2019-04-26 AU AU2019260644A patent/AU2019260644B2/en active Active
- 2019-04-26 SG SG11202010623YA patent/SG11202010623YA/en unknown
- 2019-04-26 BR BR112020022016-7A patent/BR112020022016A2/pt unknown
- 2019-04-26 US US17/050,431 patent/US12440478B2/en active Active
- 2019-04-26 WO PCT/IB2019/053459 patent/WO2019207548A1/fr not_active Ceased
- 2019-04-26 EP EP19793762.6A patent/EP3799593A4/fr active Pending
-
2020
- 2020-10-27 IL IL278322A patent/IL278322B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210275502A1 (en) | 2021-09-09 |
| JP7520810B2 (ja) | 2024-07-23 |
| SG11202010623YA (en) | 2020-11-27 |
| US12440478B2 (en) | 2025-10-14 |
| IL278322B1 (en) | 2023-04-01 |
| CA3098522A1 (fr) | 2019-10-31 |
| JP2021522338A (ja) | 2021-08-30 |
| AU2019260644A1 (en) | 2020-12-17 |
| WO2019207548A1 (fr) | 2019-10-31 |
| BR112020022016A2 (pt) | 2021-02-23 |
| AU2019260644B2 (en) | 2024-02-22 |
| EP3799593A1 (fr) | 2021-04-07 |
| EP3799593A4 (fr) | 2022-03-09 |
| WO2019207548A4 (fr) | 2019-12-19 |
| IL278322B2 (en) | 2023-08-01 |
| IL278322A (fr) | 2020-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3862348A4 (fr) | Composé d'isoindoline, procédé de préparation, composition pharmaceutique et utilisation associée | |
| EP3964516A4 (fr) | Composé oxaazaquinazoline-7(8h)-cétone, son procédé de préparation et son application pharmaceutique | |
| EP3486242A4 (fr) | Dérivé d'oxopicolinamide, son procédé de préparation et son utilisation pharmaceutique | |
| EP3750887A4 (fr) | Dérivé de biaryle, son procédé de préparation, et son application pharmaceutique | |
| EP3459940A4 (fr) | Dérivé de 5-aminopyrazole carboxamide en tant qu'inhibiteur de la btk, son procédé de préparation et composition pharmaceutique associée | |
| EP3647310A4 (fr) | Procédé de préparation de 2,5-furandiméthylcarboxylate à partir d'hydroxyméthylfurfural | |
| EP3349587A4 (fr) | Procédé de préparation d'un composé antifongique | |
| EP3683205A4 (fr) | Procédé de préparation d'isocyanate aliphatique | |
| EP3892625A4 (fr) | Composé oxyde d'acylphosphine et procédé de préparation associé | |
| EP3502105A4 (fr) | Forme polymorphe d'un composé inhibiteur de kinase, composition pharmaceutique le contenant, son procédé de préparation et son utilisation | |
| EP3473625A4 (fr) | Procédé de préparation d'un composé de pyrrolopyrimidine chiral | |
| EP3594216A4 (fr) | Composé hétérocyclique à cinq chaînons d'aminopyrimidine, intermédiaire, procédé de préparation, composition pharmaceutique et application de celui-ci | |
| EP3733648A4 (fr) | Procédé de préparation d'acide 5r-benzyloxyaminopipéridin-2s-carboxylique ou d'un dérivé de celui-ci | |
| EP3564208A4 (fr) | Procédé de préparation d'un dérivé d'acide malonique 2-(cyclohexénylène) et son utilisation | |
| EP3363803A4 (fr) | Composé d'acide borique peptoïde à base d'urée, composition pharmaceutique contenant ce composé, procédé de préparation et utilisations de celui-ci | |
| EP3640239A4 (fr) | Sel pharmaceutiquement acceptable d'alkylcarbamoyl naphtalényloxy octénoylhydroxyamide ou d'un dérivé de celui-ci et son procédé de préparation | |
| EP3495339A4 (fr) | Procédé de préparation d'un produit de réaction | |
| EP3696168A4 (fr) | Procédé de préparation de 2-chloro-5-trifluorométhylpyridine | |
| EP3644335A4 (fr) | Procédé de préparation d'un matériau actif d'anode pour pseudo-condensateur | |
| EP3889160A4 (fr) | Composé de thiamine, son procédé de préparation et composition pharmaceutique associée | |
| EP4062906A4 (fr) | Composition pharmaceutique orale comprenant un composé carbamate et procédé de préparation de cette composition | |
| EP3663322A4 (fr) | Procédé de préparation d'oligomère de butène | |
| EP3786152A4 (fr) | Procédé de préparation de composé nitrile aromatique | |
| EP3689858A4 (fr) | Nouveau procédé de préparation d'un composé de (2r)-2-(2-méthoxyphényl)-2-(oxane-4-yloxy)éthane-1-ol, et intermédiaire utilisé à cet effet | |
| EP3988547A4 (fr) | Dérivé d'indazole, son procédé de préparation et son application pharmaceutique |